Recherche pour: "{search_term_string}"

...study evaluating the long-term assessment of breast fibroadenoma (benign tumor) volume reduction following treatment with the company’s Echopulse®, a non-invasive treatment employing ultrasound-guided high-intensity focused ultrasound. The study, entitled “Long-term...

New Clinical Data Strongly Support the Safety and Efficacy of Theraclion’s Echotherapy System Publication of first comparative study demonstrates positive mid-term results with Echopulse® New results presented at ETA and...

First international, multicentric study to present long-term results of echotherapy in breast fibroadenoma. Read the press release...

...in cases of metastatic breast cancer via the combined effects of echotherapy and pembrolizumab   THERACLION today announced its long-term academic partner, University of Virginia (UVA), has received authorization from...

Theraclion aligns its investor structure and financial leadership with its long-term commercial ambitions   THERACLION is pleased to announce the investment of a major German bank into its capital on...